News, features, and commentary about cancer-related issues
— News, features, and commentary about cancer-related issues
June 12, 2026
• 2 min read
Scammers used the identity of Brian Druker, MD, the renowned leukemia researcher known for his work developing imatinib (Gleevec), to pitch ivermectin as a cancer cure. (OregonLive)
A phase III trial involving lurbinectedin (Zepzelca) in pretreated metastatic small cell lung cancer failed to meet its primary endpoint of overall survival, Jazz Pharmaceuticals announced.
Stay up to date with notifications from The IndependentNotifications can be managed in browser…
Pathologist and athlete who was Australian of the year in 2024 underwent a bold experimental treatment after devastating brain…
Prof Richard Scolyer’s groundbreaking work on immunotherapy revolutionised treatment of advanced melanoma
Early detection, innovative drugs and a better understanding of lung cancer is resulting in improved outcomes for people with the…
A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.
LUND, SE / ACCESS Newswire / June 1, 2026 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a leader in the…
